ProThera Biologics Awarded $2-Million Fast Track NIH Grant

ProThera Biologics Awarded $2-Million Fast Track NIH Grant Company is Developing an Important Biomarker to Assess Outcomes in Neonates with Sepsis or Necrotizing Enterocolitis (NEC) in Support of Its Therapeutic  Development Programs Providence, R.I., June 19, 2019 –...